Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024

SELL
$13.56 - $20.78 $58,308 - $89,354
-4,300 Reduced 70.49%
1,800 $25,000
Q4 2023

Feb 14, 2024

BUY
$14.18 - $22.31 $86,498 - $136,091
6,100 New
6,100 $131,000
Q4 2019

Feb 14, 2020

SELL
$76.41 - $117.54 $68,769 - $105,786
-900 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$61.52 - $91.1 $123,040 - $182,200
-2,000 Reduced 68.97%
900 $77,000
Q2 2019

Aug 14, 2019

BUY
$58.04 - $66.99 $168,316 - $194,270
2,900 New
2,900 $188,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $131M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.